Michael Grau

Muenster, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications

LNS-8801 as a therapeutic agent for aggressive lymphomas: ROS-induced cytotoxicity and synergy with existing therapies.

LNS-8801 as a therapeutic agent for aggressive lymphomas: ROS-induced cytotoxicity and synergy with existing therapies.

Journal: Blood advances
Published: February 11, 2025

Common hereditary variants of the APOE gene and posttransplant outcome in acute myeloid leukemia.

Common hereditary variants of the APOE gene and posttransplant outcome in acute myeloid leukemia.

Journal: Blood
Published: September 10, 2024

Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphoma.

Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphoma.

Journal: Nature cancer
Published: June 28, 2024

Quality of life assessment in diffuse large B-cell lymphoma (DLBCL) in REFLECT: a prospective, non-interventional, multicenter, German study, assessing Sandoz rituximab in combination with CHOP.

Quality of life assessment in diffuse large B-cell lymphoma (DLBCL) in REFLECT: a prospective, non-interventional, multicenter, German study, assessing Sandoz rituximab in combination with CHOP.

Journal: Annals of hematology
Published: February 29, 2024

Identification of Tensin-3 as a MALT1 substrate that controls B cell adhesion and lymphoma dissemination.

Identification of Tensin-3 as a MALT1 substrate that controls B cell adhesion and lymphoma dissemination.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 18, 2023

Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms.

Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms.

Journal: Leukemia
Published: June 16, 2023

Oncogene-induced MALT1 protease activity drives posttranscriptional gene expression in malignant lymphomas.

Oncogene-induced MALT1 protease activity drives posttranscriptional gene expression in malignant lymphomas.

Journal: Blood
Published: June 09, 2023

Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma.

Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma.

Journal: Frontiers in immunology
Published: May 10, 2023

BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosis.

BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosis.

Journal: Blood
Published: December 02, 2022

Transcriptional reprogramming by mutated IRF4 in lymphoma.

Transcriptional reprogramming by mutated IRF4 in lymphoma.

Journal: Nature communications
Published: November 29, 2022

Molecular profiling of EBV associated diffuse large B-cell lymphoma.

Molecular profiling of EBV associated diffuse large B-cell lymphoma.

Journal: Leukemia
Published: September 21, 2022

Identifying plastics with photoluminescence spectroscopy and machine learning.

Identifying plastics with photoluminescence spectroscopy and machine learning.

Journal: Scientific reports
Published: August 16, 2022
Showing 1-12 of 43

Last Updated: 09/26/2026